The optics specialist punched out one of its best quarters ever, yet the stock took a modest hit Friday following the completion of a debt-for-equity exchange that temporarily spooked some holders. Lumentum’s shares slid roughly 3.5% to €786.60, pulling further away from the 52-week high of €920 — but that move looks more like a breather than a reversal for a stock that has more than doubled this year.
On June 4, Lumentum wrapped up a deal with holders of its 0.50% convertible notes due 2028, swapping about 5.0 million shares for $650.4 million in outstanding debt. The resulting dilution was modest — roughly 800,000 additional shares — and the trade-off strengthens equity while trimming interest expense. The market’s slight retreat is the kind of mechanical noise that tends to fade once the next earnings cycle arrives.
Record Revenue and a Supply Squeeze That Won’t Quit
The operational story remains extraordinary. For the third fiscal quarter of 2026, Lumentum posted revenue of $808 million, a 90% surge year-over-year, while non-GAAP operating margin expanded by more than 2,100 basis points. The momentum is being driven by red-hot demand for transceivers and laser chips — products that are essential to the optical networks powering AI infrastructure.
Management has guided for another record in the current quarter, with revenue between $960 million and $1.01 billion and non-GAAP earnings per share of $2.85 to $3.05. Demand continues to outrun supply by roughly 30%, this despite a 40% capacity expansion already underway. The entire production run of electro-absorption modulated lasers is spoken for under long-term contracts extending through 2027.
Should investors sell immediately? Or is it worth buying Lumentum?
Nvidia’s $2 Billion Vote of Confidence
The strategic value of Lumentum’s optical technology was underscored in April when Nvidia committed $2 billion to the company, earmarking the funds for joint research into next-generation optical systems for AI data centers. The partnership also supports Lumentum’s build-out of a U.S. manufacturing facility, giving the company a multi-year demand outlook — particularly for its indium phosphide lasers and work on co-packaged optics.
Analysts have responded with a wave of upgrades. Rosenblatt bumped its price target from $900 to $1,300; Loop Capital went to $1,400. JPMorgan, Jefferies, Raymond James, Barclays, Mizuho and CFRA all raised their targets, the majority landing above $1,000 with buy ratings. The stock’s inclusion in the Nasdaq-100 in May has also shifted the shareholder base, drawing in ETFs and photonics-focused funds.
Even after Friday’s dip, Lumentum shares trade 90% above their 200-day moving average and have climbed 138% since the start of the year. The valuation may look stretched, but the growth trajectory — reinforced by record guidance, Nvidia’s backing, and a supply shortfall that shows no sign of easing — gives the bulls ample ammunition for now.
Ad
Lumentum Stock: Buy or Sell?! New Lumentum Analysis from June 5 delivers the answer:
The latest Lumentum figures speak for themselves: Urgent action needed for Lumentum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 5.
Lumentum: Buy or sell? Read more here...









